Principal Financial Group
MLAB icon

Principal Financial Group’s Mesa Laboratories MLAB Stock Holding History

Principal Financial Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
12,069
+981
+9% +$98.7K ﹤0.01% 1919
2026
Q1 		$980K Sell
11,088
-3,804
-26% -$328K ﹤0.01% 1945
2025
Q4 		$1.17M Buy
14,892
+4,827
+48% +$367K ﹤0.01% 1929
2025
Q3 		$674K Sell
10,065
-19,713
-66% -$1.42M ﹤0.01% 1997
2025
Q2 		$2.81M Sell
29,778
-13,881
-32% -$1.52M ﹤0.01% 1738
2025
Q1 		$5.18M Buy
43,659
+5,300
+14% +$722K ﹤0.01% 1557
2024
Q4 		$5.06M Buy
38,359
+3,252
+9% +$399K ﹤0.01% 1589
2024
Q3 		$4.56M Buy
35,107
+6,292
+22% +$740K ﹤0.01% 1604
2024
Q2 		$2.5M Sell
28,815
-904
-3% -$94.7K ﹤0.01% 1730
2024
Q1 		$3.26M Buy
29,719
+891
+3% +$89.8K ﹤0.01% 1701
2023
Q4 		$3.02M Sell
28,828
-125,937
-81% -$12.3M ﹤0.01% 1706
2023
Q3 		$16.3M Sell
154,765
-3,872
-2% -$496K 0.01% 928
2023
Q2 		$20.4M Sell
158,637
-5,051
-3% -$770K 0.01% 833
2023
Q1 		$28.6M Buy
163,688
+13,166
+9% +$2.36M 0.02% 645
2022
Q4 		$25M Buy
150,522
+11,932
+9% +$1.87M 0.02% 685
2022
Q3 		$19.5M Buy
138,590
+10,258
+8% +$1.87M 0.02% 787
2022
Q2 		$26.2M Buy
128,332
+15,580
+14% +$3.41M 0.02% 658
2022
Q1 		$28.7M Buy
112,752
+22,017
+24% +$5.98M 0.02% 691
2021
Q4 		$29.6M Buy
90,735
+16,855
+23% +$5.29M 0.02% 687
2021
Q3 		$22.3M Buy
73,880
+40,104
+119% +$11.4M 0.01% 855
2021
Q2 		$9.16M Sell
33,776
-742
-2% -$188K 0.01% 1471
2021
Q1 		$8.4M Sell
34,518
-136
-0.4% -$37.4K 0.01% 1468
2020
Q4 		$9.93M Sell
34,654
-21
-0.1% -$5.78K 0.01% 1230
2020
Q3 		$8.83M Buy
34,675
+4,462
+15% +$1.06M 0.01% 1147
2020
Q2 		$6.55M Sell
30,213
-256
-0.8% -$59K 0.01% 1300
2020
Q1 		$6.89M Sell
30,469
-1,257
-4% -$310K 0.01% 1118
2019
Q4 		$7.91M Sell
31,726
-2,496
-7% -$585K 0.01% 1365
2019
Q3 		$8.14M Buy
34,222
+3,183
+10% +$736K 0.01% 1319
2019
Q2 		$7.58M Buy
+31,039
New +$7.23M 0.01% 1369

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group's MLAB Position: Q2 2026 in Review

Principal Financial Group increased its Mesa Laboratories (MLAB) stake by 8.8% in Q2 2026, buying an estimated $98.7K and bringing the position to 12,069 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Principal Financial Group first reported a position in MLAB in Q2 2019 and has held it in 29 quarters since. The position peaked at $29.6M in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Principal Financial Group held 12,069 shares of Mesa Laboratories worth $1.2M as of Q2 2026.
  • Principal Financial Group bought 981 Mesa Laboratories shares in Q2 2026, an estimated $98.7K.
  • Mesa Laboratories made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1919 holding.
  • Principal Financial Group first reported a position in Mesa Laboratories in Q2 2019 and has held it in 29 quarters since.
  • Principal Financial Group's Mesa Laboratories position peaked at $29.6M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.